7th International Conference for Cancer Immunotherapy & Immunomonitoring (CITIM)

SB-PEPTIDE is pleased to exhibit during the 7th CITIM Internation Conference which will be held in Vilnius, Lithuania, from April 24th to 27th, 2023.

SB-PEPTIDE 7th International Conference for Cancer Immunotherapy & Immunomonitoring participation banner

Meet our delegate at Booth #4


Epitopes (OVA, MOG...)
Pools (CEF, PP65...)
Libraries (Spike...)

Marine Hoscar

Marine Hoscar

Business developer & Scientific Data Analyst

"Recently graduated in chemical engineering with a specialization in biochemistry, I decided to temporarily leave the laboratory to help SB-PEPTIDE broaden its market internationally. I am thrilled to be the main point of contact for all kinds of peptide requests (custom synthesis, peptide catalog, analytical services) and I hope to meet scientific experts through various congresses I will attend. Feel free to contact me on LinkedIn or at mh@sb-peptide.com for more information."

About 7th International Conference for Cancer Immunotherapy & Immunomonitoring (CITIM)

This year’s CITIM International Conference will bring the best world clinicians and scientists to Eastern Europe to participate in plenary sessions, symposia and educational workshops designed to maintain, improve and further develop the investigation and practice of malignant diseases. The target audience includes biomedical scientists, medical students, immunologists, medical oncologists, surgical oncologists, hematologists, pathologists, specialty and primary care physicians, and allied health professionals.

Lecturers are invited from the USA, Israel, Germany, France, Italy, Spain, Poland, Netherlands, Denmark, Czech Republic, Australia, UK, Canada and other countries. A special attention will be given to novel therapeutic modalities, tumor immunology and immunotherapy, stem cells, cancer biomarkers, the tumor immunoenvironment and immunomonitoring of the immune status of cancer patients.

Visit the 7th CITIM International Conference website !